CELLPOINT stock news
This page provides real-time market news, earnings updates, and company announcements related to Cell Point (India) Limited (CELLPOINT).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-11 03:46 IST
Akari Therapeutics Participates in Virtual Investor "What This Means" Interview Discussing Strategic Partnership with WuXi XDC
Finviz2026-04-09 12:54:48
Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026
Finviz2026-04-09 13:09:53
SAIC Appoints AI Expert Paul Eremenko and Cybersecurity Leader Admiral Mike Rogers to Board of Directors
Finviz2026-04-09 13:18:02
BDTX: Insights from Silevertinib Data on EGFR NSCLC Growth Potential
101 finance2026-04-09 17:18:52
Albemarle: Why Sodium-Ion Technology Makes This Lithium Giant A Value Trap
101 finance2026-04-09 20:48:48
Charles River’s cardiovascular diagnostics initiative aims at an 11.5% CAGR total addressable market, with divestitures driving improved margins and increased earnings potential
101 finance2026-04-09 21:04:02
Prediction: QuantumScape (QS) Stock Is a Buy Before April 22
101 finance2026-04-10 06:33:12
Momentum Stocks: A Fundamental Standout and Two Pitfalls for Long-Term Investors
101 finance2026-04-10 08:21:39
Amgen's Tarlatamab China Approval: What's Priced In and What's Not
101 finance2026-04-10 08:39:43
Starlink's Growing Reach Supports $2 Trillion SpaceX IPO Value
101 finance2026-04-10 09:45:41
FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity
Finviz2026-04-10 12:36:05
Zacks Industry Outlook Features EchoStar, Planet Labs PBC, and Iridium Communications
101 finance2026-04-10 12:40:02
eXoZymes Achieves Scalable NCT Manufacturing with Pharmaceutical-Grade Purity—Paving the Way for a New Era in Cell-Free Biomanufacturing
101 finance2026-04-10 13:33:45
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
Finviz2026-04-10 13:57:05
Thermo Fisher Shares Could See Gains After Teaming Up With PRECISE
101 finance2026-04-10 15:12:46
BE - CoreWeave Deal Play: AI Datacenter Infrastructure Breakout
TradingView2026-04-10 17:18:16
BMY Up 10% This Year: Is It Time to Buy, Sell, or Hold?
101 finance2026-04-10 19:43:17
IBRX Shares Jump 7% Following Robust Preliminary Q1 2026 Results
101 finance2026-04-10 19:57:40
Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026
Finviz2026-04-10 20:06:48
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy - CORRECTION
Finviz2026-04-10 20:12:45
IDEAYA’s April 13 PFS Results May Lead to Fast-Track Approval or Significant Revaluation
101 finance2026-04-10 20:30:44
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-10 20:33:07
Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
Finviz2026-04-10 21:06:48
Exicure's Leadership Reshuffle: Bold Gamble for Survival as $3.7M Cash Shortfall and Nasdaq Delisting Deadline Loom
101 finance2026-04-10 21:27:46
Albemarle: Why Sodium-Ion Technology Makes This Lithium Giant A Value Trap
101 finance2026-04-09 20:48:48
Charles River’s cardiovascular diagnostics initiative aims at an 11.5% CAGR total addressable market, with divestitures driving improved margins and increased earnings potential
101 finance2026-04-09 21:04:02
Prediction: QuantumScape (QS) Stock Is a Buy Before April 22
101 finance2026-04-10 06:33:12
Momentum Stocks: A Fundamental Standout and Two Pitfalls for Long-Term Investors
101 finance2026-04-10 08:21:39
Amgen's Tarlatamab China Approval: What's Priced In and What's Not
101 finance2026-04-10 08:39:43
Starlink's Growing Reach Supports $2 Trillion SpaceX IPO Value
101 finance2026-04-10 09:45:41
FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity
Finviz2026-04-10 12:36:05
Zacks Industry Outlook Features EchoStar, Planet Labs PBC, and Iridium Communications
101 finance2026-04-10 12:40:02
eXoZymes Achieves Scalable NCT Manufacturing with Pharmaceutical-Grade Purity—Paving the Way for a New Era in Cell-Free Biomanufacturing
101 finance2026-04-10 13:33:45
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
Finviz2026-04-10 13:57:05
Thermo Fisher Shares Could See Gains After Teaming Up With PRECISE
101 finance2026-04-10 15:12:46
BE - CoreWeave Deal Play: AI Datacenter Infrastructure Breakout
TradingView2026-04-10 17:18:16
BMY Up 10% This Year: Is It Time to Buy, Sell, or Hold?
101 finance2026-04-10 19:43:17
IBRX Shares Jump 7% Following Robust Preliminary Q1 2026 Results
101 finance2026-04-10 19:57:40
Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026
Finviz2026-04-10 20:06:48
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy - CORRECTION
Finviz2026-04-10 20:12:45
IDEAYA’s April 13 PFS Results May Lead to Fast-Track Approval or Significant Revaluation
101 finance2026-04-10 20:30:44
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-10 20:33:07
Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
Finviz2026-04-10 21:06:48
Exicure's Leadership Reshuffle: Bold Gamble for Survival as $3.7M Cash Shortfall and Nasdaq Delisting Deadline Loom
101 finance2026-04-10 21:27:46
CELLPOINT stock price change
On the last trading day, CELLPOINT stock closed at 15.60 INR, with a price change of 0.32% for the day.
Trade stock perpsCELLPOINT stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more